Wosen JE, Mukhopadhyay D, MacAubas C, Mellins ED
Research Benefits Potential for Synergistic Benefit Researchers may investigate the combined effects of Ipamorelin, Epithalon, and CJC-1295 No DAC, exploring potential synergies in growth-related processes
As experts continue to study the impact that GLP-1s have on health outcomes, state budgets, peoples lives and out-of-pocket costs, it is expected that the drugs will remain a topic of conversation among state lawmakers, Medicaid agencies, stakeholder groups and many others during the coming 2025 legislative session
GLP-1 medications work on a dose-dependent basis , meaning higher doses often lead to greater weight loss
Implications for body composition optimization The body composition data has practical implications for protocol design